VBLOC once approved will be stiff competition against the likes of VVUS, ARNA and OREX who all sell pills with serious side effects. VBLOC is safe, people lost on average 24% of their weight and there were both hypertension and diebetic benefits.
In terms of the potential target market 69% of US is overweight to obese.
If VBLOC gathers just .001 of this market, which is 1/10 of 1%, it represents 277,000 patients per year, at $5,000 per device generates $ 1 billion in revenue.
Catalysts which will propel stock much higher:
a) October 31st, 2013 business update on response to FDA
b) FDA Panel meeting to approve VBLOC this quarter or early next quarter.
c) FDA Approval by 1/2 of 2014
d) Hiring of 100 sales people to sell VBLOC
e) Austrialian government reimbursement coverage of VBLOC costs.
The U.S. spends $ 147 billion per year in health costs to treat this overweight to obese population whom develop all sorts of medical problems due to weight.
ETRM met FDA prior to filing PMA and showed them clinical results. FDA encouraged them to file their PMA as it is acceptable to them and, are very favorable to devices which help improve health and reduce costs.
Target price of ETRM,
a) $ 3 to $ 4 before FDA Panel decision
b) $ 6 to $ 7 once FDA Panel approves
c) DOUBLE DIGITS once FDA approves.
VBLOC is a game changer, load up on shares in lots of 100,000 shares if possible and reap 1000% return in 6 months.
Look out for one poster, penny_dreaddful. He is neither long or short, yet spends his day posting negative articles on this message board to cast doubt on investing in ETRM. He is trying so hard which leads one to question his motive where he has no position. MOTIVE; he works as employee for marketing firm to put out negative articles while HEDGE FUNDS load up on ETRM before it soars 1000%.